GT Medical Technologies Names New GammaTile Center of Excellence in St. Louis
In a remarkable achievement, GT Medical Technologies has recognized SSM Health Saint Louis University Hospital as the newest GammaTile® Center of Excellence. This designation honors the hospital's exceptional commitment to enhancing patient care and pushing the boundaries of brain tumor treatment. The GammaTile procedure represents a significant advancement in the fight against malignant brain tumors, and the SSM Health team is leading the charge in its implementation.
SSM Health Saint Louis University Hospital has distinguished itself through rigorous adherence to specific clinical requirements, such as maintaining a minimum annual number of cases and ongoing education to ensure the highest level of expertise in the GammaTile procedure. This dedication is reflected in the exceptional team of surgeons working at the institution:
Dr. Philippe Mercier, who leads the neuro-oncology program at SSM Health, emphasized the comprehensive nature of their approach to treating brain tumors. "At SSM Health Saint Louis University, we have developed a comprehensive neuro-oncology program with subspecialty-trained neurosurgeons who incorporate the latest technology to improve the lives of our cancer patients," he stated. This dedication ensures that patients have access to the most advanced treatment options currently available.
The GammaTile procedure is a groundbreaking form of radiation therapy used immediately following tumor removal surgery. What sets GammaTile apart is its unique ability to deliver targeted radiation to the tumor site at the most critical moment when cancer cells are particularly vulnerable. Traditional methods often require a delayed start of radiation therapy to allow surgical wounds to heal, creating a gap that can allow remaining cancer cells to regroup. GammaTile eliminates this gap, maximizing treatment effectiveness and minimizing the risk of tumor regrowth.
The technology involves a bioabsorbable collagen implant embedded with radiation seeds, placed directly into the surgical cavity during the tumor removal process. This localized treatment approach ensures that cancer cells are treated promptly, while also reducing radiation exposure to healthy brain tissues.
Since its official market launch in March 2020, the GammaTile has gained traction and acceptance within over 100 prestigious medical centers across the United States, highlighting its growing recognition within both academic institutions and community healthcare settings. Such widespread adoption underscores a shift towards more innovative, technology-driven treatments in oncology and the increasing importance of specialized centers equipped to implement these advancements.
In addition to their focused clinical efforts on GammaTile, SSM Health Saint Louis University Hospital is also participating in multiple clinical trials aimed at refining and optimizing the use of this innovative technology. This commitment to research not only enhances their current treatment protocols but also positions them at the forefront of developing future solutions in brain tumor care.
About GT Medical Technologies
Founded by a dedicated group of brain tumor specialists, GT Medical Technologies continues to forge ahead in addressing the unmet needs in brain tumor treatment through innovative technologies and practices. Their unwavering commitment lies in improving the lives of patients afflicted by brain tumors through new, effective solutions that elevate care standards.
About GammaTile
GammaTile is distinguished as an FDA-cleared technology, primarily intended for patients with operable brain tumors. By offering immediate, localized radiation therapy directly in the surgical cavity, GammaTile significantly changes the landscape of treatment effectiveness and patient outcomes in the realm of neuro-oncology.
For more insights and information, please visit gammatile.com or follow them on social media platforms like Facebook, Instagram, LinkedIn, and X.
Recognition and Excellence
SSM Health Saint Louis University Hospital has distinguished itself through rigorous adherence to specific clinical requirements, such as maintaining a minimum annual number of cases and ongoing education to ensure the highest level of expertise in the GammaTile procedure. This dedication is reflected in the exceptional team of surgeons working at the institution:
- - Dr. Philippe Mercier, MD, PhD, Associate Professor and Division Director of Neurosurgery
- - Dr. Jeroen Coppens, MD, Professor of Neurosurgery
- - Dr. Joanna Kemp, MD, Associate Professor of Neurosurgery
- - Dr. Maheen Khan, MD, Assistant Professor of Neurosurgery
- - Dr. John Dombrowski, MD, PhD, Associate Professor of Radiation Oncology
- - Dr. Christen R. Elledge, MD, Assistant Professor of Radiation Oncology
Dr. Philippe Mercier, who leads the neuro-oncology program at SSM Health, emphasized the comprehensive nature of their approach to treating brain tumors. "At SSM Health Saint Louis University, we have developed a comprehensive neuro-oncology program with subspecialty-trained neurosurgeons who incorporate the latest technology to improve the lives of our cancer patients," he stated. This dedication ensures that patients have access to the most advanced treatment options currently available.
The GammaTile Advantage
The GammaTile procedure is a groundbreaking form of radiation therapy used immediately following tumor removal surgery. What sets GammaTile apart is its unique ability to deliver targeted radiation to the tumor site at the most critical moment when cancer cells are particularly vulnerable. Traditional methods often require a delayed start of radiation therapy to allow surgical wounds to heal, creating a gap that can allow remaining cancer cells to regroup. GammaTile eliminates this gap, maximizing treatment effectiveness and minimizing the risk of tumor regrowth.
The technology involves a bioabsorbable collagen implant embedded with radiation seeds, placed directly into the surgical cavity during the tumor removal process. This localized treatment approach ensures that cancer cells are treated promptly, while also reducing radiation exposure to healthy brain tissues.
Since its official market launch in March 2020, the GammaTile has gained traction and acceptance within over 100 prestigious medical centers across the United States, highlighting its growing recognition within both academic institutions and community healthcare settings. Such widespread adoption underscores a shift towards more innovative, technology-driven treatments in oncology and the increasing importance of specialized centers equipped to implement these advancements.
Commitment to Future Research
In addition to their focused clinical efforts on GammaTile, SSM Health Saint Louis University Hospital is also participating in multiple clinical trials aimed at refining and optimizing the use of this innovative technology. This commitment to research not only enhances their current treatment protocols but also positions them at the forefront of developing future solutions in brain tumor care.
About GT Medical Technologies
Founded by a dedicated group of brain tumor specialists, GT Medical Technologies continues to forge ahead in addressing the unmet needs in brain tumor treatment through innovative technologies and practices. Their unwavering commitment lies in improving the lives of patients afflicted by brain tumors through new, effective solutions that elevate care standards.
About GammaTile
GammaTile is distinguished as an FDA-cleared technology, primarily intended for patients with operable brain tumors. By offering immediate, localized radiation therapy directly in the surgical cavity, GammaTile significantly changes the landscape of treatment effectiveness and patient outcomes in the realm of neuro-oncology.
For more insights and information, please visit gammatile.com or follow them on social media platforms like Facebook, Instagram, LinkedIn, and X.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.